Sorry I just found an answer to one of my questions from the Patersons report.
Copyed this from the report:
Assuming the ideal outcome of Phase III approval and consequent
national license grants, Eastland can commence production on an
initial 10 million units of ArTiMistTM.
"phase iii clinical field trials" , page-2
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.159M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 425293 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 230500 | 2 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| EMS (ASX) Chart |
Day chart unavailable